[go: up one dir, main page]

WO2001038534A3 - Human serpin - Google Patents

Human serpin Download PDF

Info

Publication number
WO2001038534A3
WO2001038534A3 PCT/US2000/032100 US0032100W WO0138534A3 WO 2001038534 A3 WO2001038534 A3 WO 2001038534A3 US 0032100 W US0032100 W US 0032100W WO 0138534 A3 WO0138534 A3 WO 0138534A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine protease
serpin
serine
family
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/032100
Other languages
French (fr)
Other versions
WO2001038534A2 (en
Inventor
James L Holloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU22504/01A priority Critical patent/AU2250401A/en
Publication of WO2001038534A2 publication Critical patent/WO2001038534A2/en
Publication of WO2001038534A3 publication Critical patent/WO2001038534A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Members of the serine protease family play a role in carefully controlled processes, such as blood coagulation, fibrinolysis, complement activation, fertilization, and hormone production. The enzymatic activity of the serine proteases is regulated in part by serpins, serine protease inhibitors. Serpin dysfunction is associated with various disorders, including emphysema, blood clotting disorders, cirrhosis, Alzheimer disease, and Parkinson disease. Zserp 11 is a new member of the serine protease inhibitor family.
PCT/US2000/032100 1999-11-29 2000-11-20 Human serpin Ceased WO2001038534A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22504/01A AU2250401A (en) 1999-11-29 2000-11-20 Human serpin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45024499A 1999-11-29 1999-11-29
US09/450,244 1999-11-29

Publications (2)

Publication Number Publication Date
WO2001038534A2 WO2001038534A2 (en) 2001-05-31
WO2001038534A3 true WO2001038534A3 (en) 2002-01-03

Family

ID=23787321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/032100 Ceased WO2001038534A2 (en) 1999-11-29 2000-11-20 Human serpin

Country Status (2)

Country Link
AU (1) AU2250401A (en)
WO (1) WO2001038534A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034957A1 (en) * 1995-05-02 1996-11-07 Incyte Pharmaceuticals, Inc. Pancreas-derived serpin
WO1996040922A1 (en) * 1995-06-07 1996-12-19 Incyte Pharmaceuticals, Inc. Novel serpin derived from human hypothalamus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034957A1 (en) * 1995-05-02 1996-11-07 Incyte Pharmaceuticals, Inc. Pancreas-derived serpin
WO1996040922A1 (en) * 1995-06-07 1996-12-19 Incyte Pharmaceuticals, Inc. Novel serpin derived from human hypothalamus

Also Published As

Publication number Publication date
WO2001038534A2 (en) 2001-05-31
AU2250401A (en) 2001-06-04

Similar Documents

Publication Publication Date Title
Oliva et al. Leucaena leucocephala serine proteinase inhibitor: primary structure and action on blood coagulation, kinin release and rat paw edema
Patel et al. Purification and physicochemical characterization of a serine protease with fibrinolytic activity from latex of a medicinal herb Euphorbia hirta
CA2058935A1 (en) Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
AU623769B2 (en) Proteinase inhibitors, process for the preparation thereof and medicaments containing these
NZ606504A (en) Modified proteases that inhibit complement activation
TR199902692T2 (en) Serine protease inhibitors.
Wilson et al. Survey of the proteolytic activities degrading the Kunitz trypsin inhibitor and glycinin in germinating soybeans (Glycine max)
NZ596269A (en) Protease screening methods and proteases identified thereby
SE0201980D0 (en) Novel compounds
WO2000051623A3 (en) Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
EP0739338A4 (en) Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
MY116539A (en) New amino acid derivatives
WO2001044172A8 (en) Salicylamides as serine protease and factor xa inhibitors
WO2002061064A3 (en) Method for producing recombinant trypsin
SE0201977D0 (en) Novel compounds
WO1993009233A3 (en) Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states
WO2002014359A3 (en) Human serpin zserp15
NZ319474A (en) Guanidino protease inhibitors
WO2003099202A3 (en) Beta-secretase inhibitors
WO2001038534A3 (en) Human serpin
WO2001031033A3 (en) Protease from lucila sericata and its use in treatment of wounds
Jeong et al. Purification of a fibrinolytic enzyme (myulchikinase) from pickled anchovy and its cytotoxicity to the tumor cell lines
SE0203712D0 (en) Novel compounds
WO2003070229A3 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
HK1043534A1 (en) Protease inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase